# Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

> **NCT01325337** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 307 (actual)

## Conditions studied

- Alopecia
- Alopecia, Androgenetic
- Baldness

## Interventions

- **DRUG:** bimatoprost Formulation A
- **DRUG:** bimatoprost Formulation B
- **DRUG:** bimatoprost Formulation C
- **DRUG:** bimatoprost vehicle solution
- **DRUG:** minoxidil 5% solution

## Key facts

- **NCT ID:** NCT01325337
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325337, "Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01325337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*